Long-term Treatment with Lurasidone in Older Adults with Bipolar Depression: Results of a 6 Month Open-label Study

被引：0
|
作者：
Forester, B. [1 ]
Sajatovic, M. [2 ]
Tsai, J. [3 ]
Kroger, H. [4 ]
Pikalov, A. [5 ]
Cucchiaro, J. [5 ]
Loebel, A. [5 ]
机构：
[1] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA
[2] Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA
[3] Sunov Pharmaceut Inc, Med Affairs, Marlborough, MA USA
[4] Sunov Pharmaceut Inc, Biostat, Ft Lee, NJ USA
[5] Sunov Pharmaceut Inc, Clin Dev & Med Affairs, Ft Lee, NJ USA
来源：
EUROPEAN PSYCHIATRY | 2015年 / 30卷
关键词：
D O I：
10.1016/S0924-9338(15)30897-X
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
1134
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of long-term treatment with lurasidone in older adults with bipolar depression: results of a 6 month open-label study
    Forester, B.
    Sajatovic, M.
    Tsai, J.
    Kroger, H.
    Pikalov, A.
    Cucchiaro, J.
    Loebel, A.
    [J]. BIPOLAR DISORDERS, 2015, 17 : 132 - 132
  • [2] Efficacy and Safety of Long-term Treatment with Lurasidone in Older Adults with Bipolar Depression: Results of a 6 Month Open-label Study
    Forester, Brent
    Sajatovic, Martha
    Tsai, Joyce
    Kroger, Hans
    Pikalov, Andrei
    Cucchiaro, Josephine
    Loebel, Antony
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 23 (03): : S170 - S171
  • [3] Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study
    Forester, Brent P.
    Sajatovic, Martha
    Tsai, Joyce
    Pikalov, Andrei
    Cucchiaro, Josephine
    Loebel, Antony
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 26 (02): : 150 - 159
  • [4] LONG-TERM SAFETY AND TOLERABILITY OF LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA: RESULTS OF A 6-MONTH, OPEN-LABEL STUDY
    Stahl, Steven M.
    Cucchiaro, Josephine
    Simonelli, D.
    Severs, J.
    Loebel, A.
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 : 322 - 322
  • [5] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Cucchiaro, J.
    Silva, R.
    Hsu, J.
    Pikalov, A.
    Loebel, A.
    [J]. EUROPEAN PSYCHIATRY, 2014, 29
  • [6] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Pikalov, Andrei
    Correll, Christoph
    Cucchiaro, Josephine
    Silva, Robert
    Hsu, Jay
    Loebel, Antony
    [J]. SCHIZOPHRENIA RESEARCH, 2014, 153 : S178 - S178
  • [7] Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study
    Ketter, Terence A.
    Amchin, Jess
    Frye, Mark A.
    Gross, Nicholas
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2016, 197 : 51 - 57
  • [8] Safety and effectiveness of long-term treatment with lurasidone in children and adolescents with bipolar depression: A 6-month interim analysis of a 2-year open-label extension study
    Chang, K.
    Tocco, M.
    Goldman, R.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    [J]. EUROPEAN PSYCHIATRY, 2018, 48 : S81 - S82
  • [9] SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: WEEK 28 RESULTS OF A TWO-YEAR OPEN-LABEL EXTENSION STUDY
    Chang, Kiki
    DelBello, Melissa P.
    Goldman, Robert
    Tocco, Michael
    Pikalov, Andrei A.
    Cucchiaro, Josephine
    Loebel, Antony
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S163 - S163
  • [10] Safety of long-term treatment with lurasidone in children and adolescents with bipolar depression: week 28 results of a 2-year open-label extension study
    Chang, K.
    DelBello, M.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    [J]. BIPOLAR DISORDERS, 2018, 20 : 66 - 66
12345